Ferro-Sequels (old formulation) Interactions
There are 92 drugs known to interact with Ferro-Sequels (old formulation) (docusate / ferrous fumarate), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 4 are major, 79 are moderate, and 9 are minor.
- View all 92 medications that may interact with Ferro-Sequels (old formulation)
- View Ferro-Sequels (old formulation) alcohol/food interactions (1)
- View Ferro-Sequels (old formulation) disease interactions (5)
Most frequently checked interactions
View interaction reports for Ferro-Sequels (old formulation) (docusate / ferrous fumarate) and the medicines listed below.
- aloe vera
- alpha-lipoic acid
- Aspir 81 (aspirin)
- atenolol
- atorvastatin
- Ayr Saline Nasal (sodium chloride nasal)
- baclofen
- black cohosh
- candesartan
- CoQ10 (ubiquinone)
- Dexilant (dexlansoprazole)
- Docusil (docusate)
- dutasteride
- Eligard (leuprolide)
- Eliquis (apixaban)
- eszopiclone
- famotidine
- finasteride
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluticasone
- Gemtesa (vibegron)
- Invokana (canagliflozin)
- Jardiance (empagliflozin)
- Klonopin (clonazepam)
- Lexapro (escitalopram)
- losartan
- melatonin
- Metamucil (psyllium)
- metformin
- MiraLAX (polyethylene glycol 3350)
Ferro-Sequels (old formulation) alcohol/food interactions
There is 1 alcohol/food interaction with Ferro-Sequels (old formulation) (docusate / ferrous fumarate).
Ferro-Sequels (old formulation) disease interactions
There are 5 disease interactions with Ferro-Sequels (old formulation) (docusate / ferrous fumarate) which include:
- hemoglobin abnormalities
- inflammatory bowel disease
- intestinal obstruction disorders
- achlorhydria
- gastrointestinal irritation
Report options
More about Ferro-Sequels (old formulation) (docusate / ferrous fumarate)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
